PERCF vs LLY: Which Stock is Better?

Side-by-side comparison of Percheron Therapeutics Limited and Eli Lilly & Co in 2026

Comparison Updated:

PERCF

Percheron Therapeutics Limited

$0.00

LLY

Eli Lilly & Co

$903.99

Key Metrics Comparison

MetricPERCFLLYWinner
Market Cap$5.83M$809.09BLLY
P/E RatioN/A39.32LLY
EPS (TTM)$N/A$22.99LLY
Revenue Growth-0.4%0.4%LLY
Gross Margin89.2%83.0%PERCF

Analyze PERCF

Full quant analysis

Analyze LLY

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PERCF or LLY a better investment?

Comparing PERCF and LLY: Percheron Therapeutics Limited has a market cap of $5.83M while Eli Lilly & Co has $809.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PERCF and LLY?

PERCF (Percheron Therapeutics Limited) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PERCF or LLY?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PERCF or LLY?

LLY has higher revenue growth at 0.4% vs -0.4% for PERCF.

Which company is more profitable: PERCF or LLY?

Percheron Therapeutics Limited (PERCF) has higher gross margins at 89.2% compared to 83.0% for LLY.

Which is the larger company: PERCF or LLY?

Eli Lilly & Co (LLY) is larger with a market cap of $809.09B compared to $5.83M for PERCF.

Should I buy PERCF or LLY in 2026?

Both PERCF and LLY have investment merit. PERCF trades at $0.00 while LLY trades at $903.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PERCF and LLY stock?

Key differences: Market Cap ($5.83M vs $809.09B), P/E Ratio (N/A vs 39.3x), Revenue Growth (-0.4% vs 0.4%), Gross Margin (89.2% vs 83.0%).

Popular Stock Comparisons